Repare Therapeutics Inc.

10/07/2021 | Press release | Distributed by Public on 10/07/2021 15:12

Repare Therapeutics Issues Statement Regarding Inadvertent Issuance of Phase 1/2 TRESR RP-3500 Clinical Trial Abstract by the AACR-NCI-EORTC Virtual International Conference